2Bray F,Parkin DM. Evaluation of data quality in the cancer registry:principles and methods.Part Ⅰ:comparability,validity and timeliness[J].European Journal of Cancer,2009,(05):747-755.doi:10.1016/j.ejca.2008.11.032.
3Curado MPEB,Shin HR,Storm H. Cancer incidence in five continents[M].Lyon:IARC Scientific Publications,2008.
4Ferlay J,Burkhard C,Whelan S. Check and conversion programs for cancer registries (IARC/IACR Tools for Cancer Registries) IARC technical report No.42[M].Lyon:IARC Press,2005.
4Holly A Porter, Anthony Perry, Chris Kingsley, et al. IRS1 is highly expressed in localized breast tumors andregulates the chemotherapy, invasive breast sensitivity of breast cancer cells while IRS2 is highly expressed tumors[J]. Cancer Letters, 2013 to in 338(2): 239-248.
5Taryn L Green, Julius M Cruse, Robert E Lewis. Circulating tumor ceils (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment [J]. Experimental and molecular pathology, 2013, 95{2}.. 174-179.
6David J Klinke. induction of Wnt-inducible signaling protein-1 correiates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study [J]. PLoS computational biology, 2014, 10(1): e1003409.
7Steitz J, BrOck J, Knop J, et al. Adenovirus- transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism[J]. GeneTher, 2001, 8(16): 1255-1263.
8Cappello P, Tomaino B, Chiarle R, et al. An integrated humoral and cellular response is elicited in pancreatic cancer by alpha-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen [J]. Int J Cancer, 2009, 125(3): 639-648.
9Taryn L Green, Julius M Cruse, Robert E Lewis. Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment [J]. Experimental and molecular pathology, 2013, 95(2): 174-179.
